Theraclone Sciences Inc.
USPTO PatentsView assignee record - 16 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Theraclone ranks #18,188 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 6 technology areas.
- #18,188
- of 49,997 US assignees by volume
- Top 50%
- by Innovation Score (35.2/100)
- 16.8
- avg claims per patent
- -25%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R18188 · US Corporation #18,188 · 16 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 16 grants
- MID-PACK #18,188/49,997
- PHOTO-FINISH The Absolut Aktiebolag
- CPC-NARROW A61P · 6 areas
- INNOV-THIN 35.2/100
- CLAIMS-RICH 16.8 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -25% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: The Absolut Company Aktiebolag (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Theraclone’s 35.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Theraclone
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Theraclone Sciences · this assignee
Theraclone Sciences · this assignee
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Theraclone's Innovation Score is 35.2/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Theraclone?
Each dot is one of Theraclone’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Theraclone’s own 16.8 claims/patent is at or below the 16.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Theraclone's grants concentrate
Theraclone Sciences Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2016. By volume, Theraclone sits between The Absolut Company Aktiebolag and Thumbtack, Inc..
Theraclone's three-year grant acceleration
Theraclone Sciences Inc. shows 4 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Theraclone's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- The Absolut Aktie…
The Absolut Company Aktiebolag
16 patents
- The Children's Me…
The Children's Mercy Hospital
16 patents
- The Nanosteel
The NanoSteel Company, Inc.
16 patents
- The United States…
The United States Government as Represented by The Department of Veteran Affairs
16 patents
- Thetaray
ThetaRay Ltd.
16 patents
- Thirty-one Gifts
Thirty-One Gifts LLC
16 patents
- Thorlabs Quantum
Thorlabs Quantum Electronics, Inc.
16 patents
- Thumbtack
Thumbtack, Inc.
16 patents
- Theraclone Scienc… ◀
Theraclone Sciences Inc.
16 patents
What this shows Theraclone holds 16 patents at rank #18,208, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Theraclone
By rank, the assignees closest to #18,208 in granted patent volume.
- The Absolut Company Aktiebolag #18,204 · 16 patents
- The Children's Mercy Hospital #18,205 · 16 patents
- The NanoSteel Company, Inc. #18,206 · 16 patents
- The United States Government as Represented by The Department of Veteran Affairs #18,207 · 16 patents
- ThetaRay Ltd. #18,209 · 16 patents
- Thirty-One Gifts LLC #18,210 · 16 patents
- Thorlabs Quantum Electronics, Inc. #18,211 · 16 patents
- Thumbtack, Inc. #18,212 · 16 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Theraclone's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Theraclone's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 18.8% |
| 2016 | 1 | 6.3% |
| 2018 | 2 | 12.5% |
| 2019 | 2 | 12.5% |
| 2020 | 2 | 12.5% |
| 2022 | 1 | 6.3% |
| 2023 | 2 | 12.5% |
| 2024 | 1 | 6.3% |
| 2025partial year | 2 | 12.5% |
Which technologies does Theraclone Sciences Inc. patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Theraclone Sciences Inc.'s patent record in context - here's where to go next.
- Theraclone Sciences Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #18,188 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Theraclone Sciences Inc. against The Absolut Company Aktiebolag, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 35.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.